National Natural Science Foundation of China (Nos. 31670050, 31100069), Fundamental Research Funds for the Central Universities (No. XDJK2017B011).
Due to potent bactericidal activity and low rate of drug-resistance, daptomycin is recognized as first line antibiotic to treat serious infections caused by drug-resistant Gram-positive pathogens. However, the incidence of daptomycin resistance is increasing due to its widespread application. Alteration of cell wall homeostasis and membrane phospholipid metabolism is involved in daptomycin resistance. The unique mode of action underlying daptomycin resistance in important pathogens, including Staphylococcus aureus and Enterococci, is presented in this paper.
廖国建,彭希希,田俊,谢建平. 达托霉素耐药分子机制研究进展[J]. Chinese Journal of Biotechnology, 2018, 34(6): 832-838
Copy® 2024 All Rights Reserved